Cards

Ground-breaking clinical trial leads to life-extending treatment for people with advanced bladder cancer.

Queen Mary professors deliver pioneering trial results for hard-to-treat cancers at international cancer congress.

Research by Queen Mary academics underpins government decision to offer home testing kits for cervical cancer screening in England.

Our researchers identified the most cost-effective way to reduce breast cancer risk in high-risk women.

Our researchers revealed how rogue DNA rings drive growth in many glioblastomas, the most common and aggressive adult brain cancers.

Study shows a breath test could help detect blood cancers, which affect around 40,000 people a year in the UK, sooner.

Nature named Professor Tom Powles among its top ten science shapers for transformative bladder cancer outcomes.

Ovatools, a new tool developed by Queen Mary researchers, could help GPs identify people who may be at higher risk of ovarian cancer.

Our researchers are studying women’s breast cancer screening experiences to understand low uptake in East London and how services can be improved.

Our researchers work within Cancer Grand Challenges’ eDyNAmiC team to study extrachromosomal DNA in glioblastoma and its treatment potential.

Built on 15 years of research at Queen Mary, PancRISK is pancreatic cancer test that uses machine learning to analyse biomarkers from blood and urine.

Professor Scott and Dr Standen write about the early symptoms of brain tumours and the importance of early diagnosis.